Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: A possible explanation for its specific PAF antiaggregating effects in human platelets
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 272 (2) , 466-475
- https://doi.org/10.1016/0003-9861(89)90241-5
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Zn2+ enhances protein tyrosine kinase activity of human platelet membranesFEBS Letters, 1988
- No direct correlation between Ca2+ mobilization and dissociation of Gi during platelet phospholipase A2 activationBiochemical and Biophysical Research Communications, 1988
- Cations decrease specific [3H]-spiroperidol binding in human prefrontal cortexLife Sciences, 1986
- Androgen receptors in ventral prostate glands of zinc deficient ratsLife Sciences, 1986
- Desensitization of human platelets by platelet activating factorBiochemical and Biophysical Research Communications, 1985
- Inhibition of Enkephalin Binding to Opiate Receptors by Zinc Ions: Possible Physiological Importance in the BrainActa Pharmacologica et Toxicologica, 1982
- Effects of ticlopidine on platelet prostaglandin metabolism. possible consequences for prostacyclin productionProstaglandins and Medicine, 1979
- Pharmacology of fibrosis: Definitions, limits and perspectivesLife Sciences, 1975
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949